SNBL

The preclinical research division of Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is Japan’s largest and oldest preclinical CRO. For over 50 years, we have been able to balance speed with superior quality, because we understand just how important timelines are to our clients. SNBL’s experience and quality are valued by both our Japanese and global clients, and the GLP reports we have produced have been an integral part of submissions to regulatory authorities including the FDA, MHLW, and EMA. Our services include general toxicity, reproductive and developmental toxicity, safety pharmacology, genotoxicity, specific toxicity, and bioanalysis studies, as well as efficacy models. We have a stand-alone Pharmacokinetics and Bioanalysis Center which meets the clinical and preclinical bioanalysis needs of our clients. Contact us at [email protected] today to discuss how we can meet your safety and efficacy drug development needs.